Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Volt™ PFA System to treat patients battling atrial fibrillation (AFib). Abbott will soon begin ...
Other hot topics included new data on LAAO and conduction-system pacing, plus the go-ahead for ablation in ASCs.
TipRanks on MSN
Boston Scientific’s global pulsed field ablation trial targets persistent atrial fibrillation growth
Boston Scientific ($BSX) announced an update on their ongoing clinical study. Study OverviewThis global Boston Scientific trial, officially titled ...
Abbott will soon enter the competitive U.S. pulsed field ablation (PFA) market, having just received FDA approval for its ...
The Volt pulsed-field ablation (PFA) system (Abbott) has been approved by the US Food and Drug Administration for the treatment of patients with atrial fibrillation (AF), according to a Monday ...
Medical Device Network on MSN
FDA approves Abbott’s Volt PFA system for atrial fibrillation
The US Food and Drug Administration (FDA) has granted approval for Abbott’s Volt PFA System, expanding treatment options for ...
US FDA approves Abbott's Volt PFA System to treat patients with atrial fibrillation: Abbott Park, Illinois Wednesday, December 24, 2025, 12:00 Hrs [IST] Abbott, is a global health ...
Jordan News Agency (Petra) on MSN
Local hospital performs first cardiac ablation procedures for arrhythmia
The King Abdullah University Hospital (KAUH) has performed its first catheter-based cardiac ablation procedures for the treatment of cardiac arrhythmias, using advanced electrophysiology and cardiac ...
After claiming its approval in Europe earlier this year, Abbott has secured the FDA’s go-ahead for its Volt pulsed field ablation system for irregular heart rhythms, a step forward in an | With the U.
Abbott Laboratories (NYSE:ABT) picked up a meaningful win Monday after the FDA approved its Volt Pulsed Field Ablation system for treating atrial fibrillation, a condition that affects millions of ...
Cardiac Ablation Market by Trends, Dynamic Innovation in Technology Key Players and Forecast to 2030
Cardiac Ablation Market OverviewThe cardiac ablation market is set to grow at an impressive CAGR of approximately 13% over the forecast period, driven by a combination of clinical, technological, and ...
Catheter ablation significantly reduces cardiovascular risks and mortality in patients with both atrial fibrillation and obstructive sleep apnea. The study involved over 18,000 patients, showing a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback